Evidence map›Paper›PMID 33662323›Full record

ArticleThe Lancet. Infectious diseases2021

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply.

Philipp Koehler, P Lewis White, Paul E Verweij, Oliver A Cornely

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital.Journal of fungi (Basel, Switzerland) · 2022
    Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Philipp KoehlerDepartment I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
P Lewis WhiteMycology Reference Laboratory, Public Health Wales Microbiology Cardiff, Cardiff, UK.
Paul E VerweijDepartment of Medical Microbiology, ECMM, Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands; Center for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Oliver A CornelyDepartment I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany; Clinical Trials Centre Cologne, ZKS Köln, Cologne, Germany; German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. Electronic address: oliver.cornely@uk-koeln.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Invasive Pulmonary AspergillosisPulmonary AspergillosisConsensusHumansSARS-CoV-2

Identifiers

PMID33662323
PMCPMC8153839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.